Zai Lab Limited (NASDAQ:ZLAB) reported Q4 EPS of ($4.63), $3.52 worse than the analyst estimate of ($1.11). Revenue for the quarter came in at $215 million versus the consensus estimate of $62.79 million.
Zai Lab Limited (NASDAQ:ZLAB) reported Q4 EPS of ($4.63), $3.52 worse than the analyst estimate of ($1.11). Revenue for the quarter came in at $215 million versus the consensus estimate of $62.79 million.